MISSISSAUGA, ON / ACCESSWIRE / September 24, 2024 / Cipher Pharmaceuticals Inc (TSX:CPH) (OTCQX:CPHRF) ("Cipher") today announced that it will be presenting and participating in 1x1 meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024, at 9AM (Local Time - PST). Interim Chief Executive Officer Craig Mull will be hosting the presentation and answering questions at the conclusion.
To access the live presentation, please use the following information:
Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries
Date: Thursday, September 26, 2024
Time: 12PM Eastern Time (9AM Pacific Time)
Webcast: https://www.webcaster4.com/Webcast/Page/3056/51093
1x1 meetings will be scheduled and conducted in person at the conference venue: Fairmont Waterfront Vancouver.
The Planet MicroCap Showcase: VANCOUVER 2024 website is available here: https://planetmicrocapshowcase.com/
If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda": https://planetmicrocapshowcase.com/agenda
News Compliments of Accesswire
About Cipher Pharmaceuticals Inc
Cipher Pharmaceuticals (TSX:CPH)(OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
About Planet MicroCap
Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.
If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup
Contact:
Name: Graham Farrell
Phone: 416-842-9003
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | C$13.08 |
| Daily Change: | -0.25 -1.88 |
| Daily Volume: | 35,237 |
| Market Cap: | C$335.110M |
May 08, 2025 April 29, 2025 November 07, 2024 August 08, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
